On‐Demand Activatable PROTACs for Targeted Protein Degradation
Chemistry – A European Journal · 2026
DOI: 10.1002/chem.71283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Caiyun Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, MOE Key Lab of Biomedical Materials of Natural Macromolecules, Beijing University of Chemical …. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Prodrugs. Die Arbeit nennt 112 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Open Funding Project of the State Key Laboratory of Biopharmaceutical Preparation and Delivery.
Abstract (Originalsprache)
Targeted protein degradation (TPD) has emerged as a transformative paradigm in the biomedical research. Central to this field are Proteolysis‐targeting chimeras (PROTACs), bifunctional molecules exhibiting immense therapeutic potential, particularly in oncology and autoimmune diseases. By recruiting target proteins to E3 ubiquitin ligases, PROTACs harness the ubiquitin‐proteasome system (UPS) to induce protein degradation. This event‐driven mechanism overcomes the “target occupancy‐driven” limitations of conventional small‐molecule inhibitors, offering novel avenues for tackling undruggable targets. Despite this promise, conventional PROTACs face significant translational challenges, including poor tissue specificity, off‐target toxicity, and insufficient accumulation within the tumor microenvironment. Therefore, the development of on‐demand activatable PROTAC prodrugs, capable of spatiotemporally precise protein degradation, has become a central research focus in this field. This review systematically summarizes the design principles and research progress of three major categories of activatable PROTACs: endogenously activatable PROTACs, exogenously photo‐activatable PROTACs, and bioorthogonally activatable PROTACs. We also compare the merits and limitations of these strategies to foster a deeper understanding of the field and accelerate the clinical advancement of PROTAC‐based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, MOE Key Lab of Biomedical Materials of Natural Macromolecules, Beijing University of Chemical Technology, Beijing, China.
ORCID-Profile: Qingxin Yao, Yuan Gao
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Open Funding Project of the State Key Laboratory of Biopharmaceutical Preparation and Delivery
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Guo, C., Ren, Z., Wu, X., Yao, Q., & Gao, Y. (2026). On‐Demand Activatable PROTACs for Targeted Protein Degradation. Chemistry – A European Journal. https://doi.org/10.1002/chem.71283
Vancouver
Guo C, Ren Z, Wu X, Yao Q, Gao Y. On‐Demand Activatable PROTACs for Targeted Protein Degradation. Chemistry – A European Journal. 2026. doi:10.1002/chem.71283
BibTeX
@article{Guo2026,
author = {Guo, Caiyun and Ren, Zhibin and Wu, Xiaomei and Yao, Qingxin and Gao, Yuan},
title = {On‐Demand Activatable PROTACs for Targeted Protein Degradation},
journal = {Chemistry – A European Journal},
year = {2026},
doi = {10.1002/chem.71283}
}
EUVIMED